RVL Pharmaceuticals PLC (OTC Pink - Limited Information:RVLPQ)
| 0.0031 Delayed Data As of Dec 08 |  -0.0004 / -11.43%Today’s Change | 0.00 Today|||52-Week Range 1.45 | -99.72% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Operating Activities | Net Income / Starting Line | -41.8M | -45.2M | -109.4M | -- | |
| Depreciation | 23.6M | 46.5M | 81.6M | -- | ||
| Total Other Cash Flow | 32.9M | 91.5M | 107.0M | -- | ||
| Funds From Operations | 1.5M | 48.4M | 62.6M | -- | ||
| Funds From/For Other Operating Expenses | 46.3M | -9.5M | 25.0M | -- | ||
| Net Cash Flow - Operating Activities | -44.8M | 57.8M | 37.6M | -- | ||
| Investing | Capital Expenditures | -13.9M | -6.9M | -4.1M | -- | |
| Fixed Asset Disposal | -- | -- | 10.0K | -- | ||
| Net Assets From Acquisitions | -437.5M | -12.5M | 0.00 | -- | ||
| Net Cash Flow Investing | -453.5M | -19.4M | -4.1M | -- | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | -- | -- |
| Long Term Borrowings | 329.0M | 323.9M | 2.7M | -- | ||
| Long Term Debt Reduction | -4.3M | -338.9M | -57.2M | -- | ||
| Net Proceeds Stock Sale | 0.00 | 0.00 | 58.1M | -- | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | -- | -- | |
| Common Dividends | -23.3M | 0.00 | -2.0K | -- | ||
| Cash Dividends Paid - Total | -23.3M | 0.00 | -2.0K | -- | ||
| Other Sources - Financing | 120.2M | 128.0K | 0.00 | -- | ||
| Other Uses - Financing | 1.1M | 8.5M | 0.00 | -- | ||
| Net Cash Flow - Financing | 420.5M | -23.3M | 3.6M | -- | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -316.1K | 57.2K | -937.7K | -- | |
| Net Change In Cash | -77.7M | 15.1M | 37.0M | -- | ||
